Cannabis News Box

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 2, 2019

British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States.  Now, EPIDYOLEX has also gained approval from the European Commission, thus allowing the epilepsy treatment to be prescribed to diagnosed pat...

EPIDYOLEX